PIQ — Proteomics International Laboratories Balance Sheet
0.000.00%
Last trade - 00:00- AU$133.34m
- AU$128.30m
- AU$1.47m
- 42
- 10
- 79
- 42
Annual balance sheet for Proteomics International Laboratories, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.51 | 2.37 | 5.6 | 2.11 | 6.03 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.501 | 0.556 | 0.312 | 0.455 | 0.331 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.24 | 4.12 | 7.34 | 4.36 | 8.33 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.214 | 1.44 | 1.26 | 0.973 | 1.69 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3.62 | 5.55 | 8.6 | 5.4 | 10.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.549 | 0.622 | 0.779 | 1.7 | 1.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.635 | 1.12 | 0.99 | 2 | 1.69 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.99 | 4.44 | 7.61 | 3.39 | 8.38 |
| Total Liabilities & Shareholders' Equity | 3.62 | 5.55 | 8.6 | 5.4 | 10.1 |
| Total Common Shares Outstanding |